List of Tables
Table 1. Global Nonnarcotic Analgesics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Nonnarcotic Analgesics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Nonnarcotic Analgesics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Nonnarcotic Analgesics Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Nonnarcotic Analgesics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Nonnarcotic Analgesics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Nonnarcotic Analgesics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Nonnarcotic Analgesics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Nonnarcotic Analgesics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nonnarcotic Analgesics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nonnarcotic Analgesics, Product Type & Application
Table 12. Global Key Manufacturers of Nonnarcotic Analgesics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nonnarcotic Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonnarcotic Analgesics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nonnarcotic Analgesics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Nonnarcotic Analgesics Sales by Region (2020-2025) & (K Units)
Table 18. Global Nonnarcotic Analgesics Sales Market Share by Region (2020-2025)
Table 19. Global Nonnarcotic Analgesics Sales by Region (2026-2031) & (K Units)
Table 20. Global Nonnarcotic Analgesics Sales Market Share by Region (2026-2031)
Table 21. Global Nonnarcotic Analgesics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Nonnarcotic Analgesics Revenue Market Share by Region (2020-2025)
Table 23. Global Nonnarcotic Analgesics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Nonnarcotic Analgesics Revenue Market Share by Region (2026-2031)
Table 25. North America Nonnarcotic Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Nonnarcotic Analgesics Sales by Country (2020-2025) & (K Units)
Table 27. North America Nonnarcotic Analgesics Sales by Country (2026-2031) & (K Units)
Table 28. North America Nonnarcotic Analgesics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Nonnarcotic Analgesics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Nonnarcotic Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Nonnarcotic Analgesics Sales by Country (2020-2025) & (K Units)
Table 32. Europe Nonnarcotic Analgesics Sales by Country (2026-2031) & (K Units)
Table 33. Europe Nonnarcotic Analgesics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Nonnarcotic Analgesics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Nonnarcotic Analgesics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Nonnarcotic Analgesics Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Nonnarcotic Analgesics Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Nonnarcotic Analgesics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Nonnarcotic Analgesics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Nonnarcotic Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Nonnarcotic Analgesics Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Nonnarcotic Analgesics Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Nonnarcotic Analgesics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Nonnarcotic Analgesics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Nonnarcotic Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Nonnarcotic Analgesics Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Nonnarcotic Analgesics Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Nonnarcotic Analgesics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Nonnarcotic Analgesics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Nonnarcotic Analgesics Sales (K Units) by Type (2020-2025)
Table 51. Global Nonnarcotic Analgesics Sales (K Units) by Type (2026-2031)
Table 52. Global Nonnarcotic Analgesics Sales Market Share by Type (2020-2025)
Table 53. Global Nonnarcotic Analgesics Sales Market Share by Type (2026-2031)
Table 54. Global Nonnarcotic Analgesics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Nonnarcotic Analgesics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Nonnarcotic Analgesics Revenue Market Share by Type (2020-2025)
Table 57. Global Nonnarcotic Analgesics Revenue Market Share by Type (2026-2031)
Table 58. Global Nonnarcotic Analgesics Price (US$/Unit) by Type (2020-2025)
Table 59. Global Nonnarcotic Analgesics Price (US$/Unit) by Type (2026-2031)
Table 60. Global Nonnarcotic Analgesics Sales (K Units) by Application (2020-2025)
Table 61. Global Nonnarcotic Analgesics Sales (K Units) by Application (2026-2031)
Table 62. Global Nonnarcotic Analgesics Sales Market Share by Application (2020-2025)
Table 63. Global Nonnarcotic Analgesics Sales Market Share by Application (2026-2031)
Table 64. Global Nonnarcotic Analgesics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Nonnarcotic Analgesics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Nonnarcotic Analgesics Revenue Market Share by Application (2020-2025)
Table 67. Global Nonnarcotic Analgesics Revenue Market Share by Application (2026-2031)
Table 68. Global Nonnarcotic Analgesics Price (US$/Unit) by Application (2020-2025)
Table 69. Global Nonnarcotic Analgesics Price (US$/Unit) by Application (2026-2031)
Table 70. GlaxoSmithKline Consumer Healthcare Company Information
Table 71. GlaxoSmithKline Consumer Healthcare Description and Business Overview
Table 72. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. GlaxoSmithKline Consumer Healthcare Nonnarcotic Analgesics Product
Table 74. GlaxoSmithKline Consumer Healthcare Recent Developments/Updates
Table 75. Bayer Corporation Company Information
Table 76. Bayer Corporation Description and Business Overview
Table 77. Bayer Corporation Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bayer Corporation Nonnarcotic Analgesics Product
Table 79. Bayer Corporation Recent Developments/Updates
Table 80. Atnahs Pharma Company Information
Table 81. Atnahs Pharma Description and Business Overview
Table 82. Atnahs Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Atnahs Pharma Nonnarcotic Analgesics Product
Table 84. Atnahs Pharma Recent Developments/Updates
Table 85. Baudax Bio Company Information
Table 86. Baudax Bio Description and Business Overview
Table 87. Baudax Bio Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Baudax Bio Nonnarcotic Analgesics Product
Table 89. Baudax Bio Recent Developments/Updates
Table 90. Prestige Brands, Inc. Company Information
Table 91. Prestige Brands, Inc. Description and Business Overview
Table 92. Prestige Brands, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Prestige Brands, Inc. Nonnarcotic Analgesics Product
Table 94. Prestige Brands, Inc. Recent Developments/Updates
Table 95. Cumberland Pharmaceuticals, Inc. Company Information
Table 96. Cumberland Pharmaceuticals, Inc. Description and Business Overview
Table 97. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Cumberland Pharmaceuticals, Inc. Nonnarcotic Analgesics Product
Table 99. Cumberland Pharmaceuticals, Inc. Recent Developments/Updates
Table 100. Takeda Pharmaceutical Company Company Information
Table 101. Takeda Pharmaceutical Company Description and Business Overview
Table 102. Takeda Pharmaceutical Company Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Takeda Pharmaceutical Company Nonnarcotic Analgesics Product
Table 104. Takeda Pharmaceutical Company Recent Developments/Updates
Table 105. Pfizer Inc. Company Information
Table 106. Pfizer Inc. Description and Business Overview
Table 107. Pfizer Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Pfizer Inc. Nonnarcotic Analgesics Product
Table 109. Pfizer Inc. Recent Developments/Updates
Table 110. McNeil Consumer Healthcare Company Information
Table 111. McNeil Consumer Healthcare Description and Business Overview
Table 112. McNeil Consumer Healthcare Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. McNeil Consumer Healthcare Nonnarcotic Analgesics Product
Table 114. McNeil Consumer Healthcare Recent Developments/Updates
Table 115. Eli Lilly and Company Company Information
Table 116. Eli Lilly and Company Description and Business Overview
Table 117. Eli Lilly and Company Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Eli Lilly and Company Nonnarcotic Analgesics Product
Table 119. Eli Lilly and Company Recent Developments/Updates
Table 120. Sun Pharmaceutical Industries Company Information
Table 121. Sun Pharmaceutical Industries Description and Business Overview
Table 122. Sun Pharmaceutical Industries Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Sun Pharmaceutical Industries Nonnarcotic Analgesics Product
Table 124. Sun Pharmaceutical Industries Recent Developments/Updates
Table 125. Validus Pharmaceuticals Company Information
Table 126. Validus Pharmaceuticals Description and Business Overview
Table 127. Validus Pharmaceuticals Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Validus Pharmaceuticals Nonnarcotic Analgesics Product
Table 129. Validus Pharmaceuticals Recent Developments/Updates
Table 130. Novartis Consumer Health Company Information
Table 131. Novartis Consumer Health Description and Business Overview
Table 132. Novartis Consumer Health Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Novartis Consumer Health Nonnarcotic Analgesics Product
Table 134. Novartis Consumer Health Recent Developments/Updates
Table 135. Pacira Pharmaceuticals, Inc. Company Information
Table 136. Pacira Pharmaceuticals, Inc. Description and Business Overview
Table 137. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Pacira Pharmaceuticals, Inc. Nonnarcotic Analgesics Product
Table 139. Pacira Pharmaceuticals, Inc. Recent Developments/Updates
Table 140. Almatica Pharma Company Information
Table 141. Almatica Pharma Description and Business Overview
Table 142. Almatica Pharma Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Almatica Pharma Nonnarcotic Analgesics Product
Table 144. Almatica Pharma Recent Developments/Updates
Table 145. BioDelivery Sciences International, Inc. Company Information
Table 146. BioDelivery Sciences International, Inc. Description and Business Overview
Table 147. BioDelivery Sciences International, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. BioDelivery Sciences International, Inc. Nonnarcotic Analgesics Product
Table 149. BioDelivery Sciences International, Inc. Recent Developments/Updates
Table 150. Akron, Inc. Company Information
Table 151. Akron, Inc. Description and Business Overview
Table 152. Akron, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Akron, Inc. Nonnarcotic Analgesics Product
Table 154. Akron, Inc. Recent Developments/Updates
Table 155. Teva Pharmaceuticals, Inc. Company Information
Table 156. Teva Pharmaceuticals, Inc. Description and Business Overview
Table 157. Teva Pharmaceuticals, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Teva Pharmaceuticals, Inc. Nonnarcotic Analgesics Product
Table 159. Teva Pharmaceuticals, Inc. Recent Developments/Updates
Table 160. Heron Therapeutics Company Information
Table 161. Heron Therapeutics Description and Business Overview
Table 162. Heron Therapeutics Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Heron Therapeutics Nonnarcotic Analgesics Product
Table 164. Heron Therapeutics Recent Developments/Updates
Table 165. Assertio Therapeutics, Inc. Company Information
Table 166. Assertio Therapeutics, Inc. Description and Business Overview
Table 167. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Assertio Therapeutics, Inc. Nonnarcotic Analgesics Product
Table 169. Assertio Therapeutics, Inc. Recent Developments/Updates
Table 170. Sanofi s.A. Company Information
Table 171. Sanofi s.A. Description and Business Overview
Table 172. Sanofi s.A. Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Sanofi s.A. Nonnarcotic Analgesics Product
Table 174. Sanofi s.A. Recent Developments/Updates
Table 175. Endo Pharmaceuticals Company Information
Table 176. Endo Pharmaceuticals Description and Business Overview
Table 177. Endo Pharmaceuticals Nonnarcotic Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Endo Pharmaceuticals Nonnarcotic Analgesics Product
Table 179. Endo Pharmaceuticals Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Nonnarcotic Analgesics Distributors List
Table 183. Nonnarcotic Analgesics Customers List
Table 184. Nonnarcotic Analgesics Market Trends
Table 185. Nonnarcotic Analgesics Market Drivers
Table 186. Nonnarcotic Analgesics Market Challenges
Table 187. Nonnarcotic Analgesics Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nonnarcotic Analgesics
Figure 2. Global Nonnarcotic Analgesics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nonnarcotic Analgesics Market Share by Type: 2024 & 2031
Figure 4. Salicylates Product Picture
Figure 5. Anilines Product Picture
Figure 6. Pyrazolones Product Picture
Figure 7. Other Product Picture
Figure 8. Global Nonnarcotic Analgesics Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Nonnarcotic Analgesics Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Pharmacy
Figure 12. Specialist Clinic
Figure 13. Other
Figure 14. Global Nonnarcotic Analgesics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Nonnarcotic Analgesics Market Size (2020-2031) & (US$ Million)
Figure 16. Global Nonnarcotic Analgesics Sales (2020-2031) & (K Units)
Figure 17. Global Nonnarcotic Analgesics Average Price (US$/Unit) & (2020-2031)
Figure 18. Nonnarcotic Analgesics Report Years Considered
Figure 19. Nonnarcotic Analgesics Sales Share by Manufacturers in 2024
Figure 20. Global Nonnarcotic Analgesics Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Nonnarcotic Analgesics Players: Market Share by Revenue in Nonnarcotic Analgesics in 2024
Figure 22. Nonnarcotic Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Nonnarcotic Analgesics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Nonnarcotic Analgesics Sales Market Share by Country (2020-2031)
Figure 25. North America Nonnarcotic Analgesics Revenue Market Share by Country (2020-2031)
Figure 26. United States Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Nonnarcotic Analgesics Sales Market Share by Country (2020-2031)
Figure 29. Europe Nonnarcotic Analgesics Revenue Market Share by Country (2020-2031)
Figure 30. Germany Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Nonnarcotic Analgesics Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Nonnarcotic Analgesics Revenue Market Share by Region (2020-2031)
Figure 37. China Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Nonnarcotic Analgesics Sales Market Share by Country (2020-2031)
Figure 47. Latin America Nonnarcotic Analgesics Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Nonnarcotic Analgesics Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Nonnarcotic Analgesics Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Nonnarcotic Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Nonnarcotic Analgesics by Type (2020-2031)
Figure 57. Global Revenue Market Share of Nonnarcotic Analgesics by Type (2020-2031)
Figure 58. Global Nonnarcotic Analgesics Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Nonnarcotic Analgesics by Application (2020-2031)
Figure 60. Global Revenue Market Share of Nonnarcotic Analgesics by Application (2020-2031)
Figure 61. Global Nonnarcotic Analgesics Price (US$/Unit) by Application (2020-2031)
Figure 62. Nonnarcotic Analgesics Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
